RECLAST- zoledronic acid injection, solution
Novartis Pharmaceuticals Corporation
----------
This Medication Guide has been approved by the U.S. Food and Drug Administration. | Revised: April 2020 |
MEDICATION GUIDE
Reclast® (RE-clast) (zoledronic acid) Injection |
|
Read the Medication Guide that comes with Reclast before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your doctor about your medical condition or treatment. Talk to your doctor if you have any questions about Reclast. | |
What is the most important information I should know about Reclast? You should not receive Reclast if you are already receiving Zometa. Both Reclast and Zometa contain zoledronic acid. Reclast can cause serious side effects, including:
1. Low calcium levels in your blood (hypocalcemia). Reclast may lower the calcium levels in your blood. If you have low blood calcium before you start taking Reclast, it may get worse during treatment. Your low blood calcium must be treated before you take Reclast. Most people with low blood calcium levels do not have symptoms, but some people may have symptoms. Call your doctor right away if you have symptoms of low blood calcium, such as:
Your doctor may prescribe calcium and vitamin D to help prevent low calcium levels in your blood, while you take Reclast. Take calcium and vitamin D as your doctor tells you to. 2. Severe kidney problems. Severe kidney problems may happen when you take Reclast. Severe kidney problems may lead to hospitalization or kidney dialysis and can be life-threatening. Your risk of kidney problems is higher if you:
You should drink at least 2 glasses of fluid within a few hours before receiving Reclast to reduce the risk of kidney problems. 3. Severe jaw bone problems (osteonecrosis). Severe jaw bone problems may happen when you take Reclast. Your doctor should examine your mouth before you start Reclast. Your doctor may tell you to see your dentist before you start Reclast. It is important for you to practice good mouth care during treatment with Reclast. 4. Unusual thigh bone fractures. Some people have developed unusual fractures in their thigh bone. Symptoms of a fracture may include new or unusual pain in your hip, groin, or thigh. 5. Bone, joint, or muscle pain. Some people who take bisphosphonates develop severe bone, joint, or muscle pain. Call your doctor right away if you have any of these side effects. |
|
What is Reclast?
Reclast is a prescription medicine used to:
Reclast is not for use in children. |
|
Who should not take Reclast?
Do not take Reclast if you:
|
|
What should I tell my doctor before taking Reclast? Before you start Reclast, be sure to talk to your doctor if you:
Know the medicines you take. Keep a list of them and show it to your doctor and pharmacist each time you get a new medicine. |
|
How will I receive Reclast?
|
|
What are the possible side effects of Reclast?
Reclast may cause serious side effects.
You may get allergic reactions, such as hives, swelling of your face, lips, tongue, or throat. Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Reclast. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. |
|
General information about safe and effective use of Reclast.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. This Medication Guide summarizes the most important information about Reclast. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about Reclast that is written for health professionals. For more information, go to: www.novartis.us or call 1-888-669-6682. |
|
What are the ingredients in Reclast?
Active ingredient: zoledronic acid monohydrate. Inactive ingredients: mannitol and sodium citrate. Distributed by: Novartis Pharmaceuticals Corporation East Hanover, New Jersey 07936 © Novartis |
T2020-63